K2 HealthVentures Provides $50MM Credit Facility to Acumen Pharmaceuticals
Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company, entered into a senior secured loan and security agreement with K2 HealthVentures, a healthcare-focused specialty finance company.
November 13, 2023
Acumen Pharmaceuticals | Daniel O’Connell | K2 HealthVentures | Nimesh Shah
Ian Koplin